Ergoteles’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-23,000
| Closed | -$251K | – | 1667 |
|
2022
Q4 | $251K | Sell |
23,000
-6,530
| -22% | -$71.2K | 0.01% | 979 |
|
2022
Q3 | $249K | Buy |
+29,530
| New | +$249K | 0.01% | 1075 |
|
2021
Q1 | – | Sell |
-11,700
| Closed | -$236K | – | 1007 |
|
2020
Q4 | $236K | Buy |
+11,700
| New | +$236K | 0.01% | 573 |
|